Examples of NK cells with a similar phenotype exist for cancer patients, including increased levels of CD56+CD16dim/neg cells in tumor specimens from patients with breast cancer [2], non-small cell lung cancer (NSCLC) [3, 26], and colorectal cancer [27, 28]. This evidence concerns the gene NCAM1 and breast carcinoma.